Related Experiment Video
Updated: Jan 14, 2026

12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.9K
Assessing Alzheimer's Disease Risk Among Latina/o/x Older Adults: A CART Analysis
Sung Seek Moon1, Javier F Boyas2, Jinwon Lee1
1Diana R. Garland School of Social Work, Baylor University, Waco, Texas76798, USA.
Current Alzheimer Research
|October 23, 2025
Summary
Alzheimer
Area of Science:
- Neuroscience
- Public Health
- Gerontology
Background:
- Alzheimer's Disease (AD) disproportionately affects Latina/o/x elders in the U.S.
- Understanding AD risk factors in this demographic is crucial for targeted interventions.
Purpose of the Study:
- To examine key risk factors associated with Alzheimer's Disease in the Latina/o/x elder population.
- To identify sociodemographic and lifestyle factors influencing AD risk.
Main Methods:
- Analysis of National Alzheimer's Coordinating Center data (N=9,801 Latina/o/x older adults).
- Utilized Chi-square tests, t-tests, and Classification and Regression Tree (CART) analysis.
- CART model identified key predictors and risk thresholds.
Main Results:
- Key predictors of AD risk included age, education level, smoking history, BMI, hypertension, and medication use.
- A critical threshold of less than 5.5 years of education, combined with age and smoking, significantly increased AD risk.
- The CART model showed modest discriminative ability (AUC=0.68).
Conclusions:
- Sociodemographic factors like gender, age, and education are critical in determining AD risk for Latina/o/x elders.
- Specific thresholds in age and education impact AD risk.
- Findings support targeted interventions focusing on education and lifestyle modifications.
More Related Videos
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.6K
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.7K
Related Concept Videos
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811